Skip to main content
Visualsonic logo
Account
  • Login
Back
  • Products
    • Products
    • Imaging Systems
      • Vevo F2xc
      • Vevo LAZR-X20
      • Vevo F2xc LT
    • Transducers
      • Browse All Transducers
      • Vevo Optical Fibers and Jackets
    • Vevo LAB Analysis Suite
      • About Vevo LAB
      • Vevo CQ
      • Vevo Strain 2.0
      • Vevo Multiplexer
      • LV Analysis
      • Auto LV
      • Update your Vevo LAB Software
    • Imaging Modes Software
      • High-frequency Ultrasound Imaging
        • All Imaging Modes
        • 4D-Mode
        • B-Mode
        • 3D-Mode
        • M-Mode
        • Anatomical M-Mode
        • Non-linear Contrast Mode
        • Power Doppler Mode
        • Pulsed-Wave Doppler Mode
        • Color Doppler Mode
        • Tissue Doppler Imaging
        • Digital RF-Mode
        • ECG and Respiration Gating
        • EKV
        • Shear Wave Elastography
      • Photoacoustic Imaging
        • Single Wavelength
        • Oxy-hemo
        • Spectro
        • Multi-wavelength
        • PA EKV
      • Acoustics & Engineering
        • VADA
    • Accessories
      • Vevo Imaging Station
      • Vevo Whole Body Imaging
      • Vevo Animal Monitoring System
      • Vevo Infusion Pump
      • Vevo PHANTOM
      • Vevo BRAIN
    • Contrast Agents
      • Photoacoustic Contrast Agents
        • About PA Contrast Agents
        • Angiostamp™800
      • Ultrasound Contrast Agents
        • Vevo MicroMarker
  • Applications
    • Applications
    • Preclinical
      • Cardiology
      • Oncology
      • Neurobiology
      • Biomarker/Molecular Imaging
      • Vascular Biology
      • Developmental
      • Image-guided Injection
      • Theranostics
      • Ischemia/Reperfusion
      • Drug Discovery and Development
      • Colorectal
      • Urogenital
      • Kidney
      • Liver
      • Fibrosis
      • Pulmonary
      • Pancreas
      • MSK
  • Resources
    • Resources
    • FAQ
    • Education
      • Learning Hub: Online Tutorials
      • Tips and Tricks
      • JoVE Videos
      • Request Training
      • Vevo University
      • In vivo Imaging
    • News and Stories
      • Shared Stories
      • Vevo Blog
      • Research Spotlight
      • Case Studies
    • Grants & Fundings
      • Vevo International Student Awards
      • Grant Support
      • List of Grants & Funding
      • Funded Projects
    • Publications Library
    • Image Gallery
    • Recorded Webinars
    • On Demand Videos
  • Events
    • Events
    • Conferences and Society Meetings
    • Upcoming Webinars
    • Upcoming Workshops
  • Support
    • Support
    • Scientific Support
    • Technical Support
    • Vevo Service Plans
    • Request Training
    • FAQ
  • Our Company
    • Our Company
    • About Us
    • News
    • Our Technology
      • Our Technology
      • Ultra High-Frequency Ultrasound
      • Photoacoustics (PA)
      • Imaging Modes
    • Scientific Advisory Board
    • Patents
  • Contact
    • Contact
    • Contact Us
    • Our Global Offices
    • Maps and Directions
    • Distributors
  • Careers
    • Careers
    • Open Positions at VisualSonics
    • External Job Postings

Search

Publication
Mutations in TGF-β–activated kinase 1 binding protein 2 (TAB2) have been implicated in the pathogenesis of dilated cardiomyopathy and/or congenital heart disease in humans, but the underlying mechanisms are currently unknown. Here, we identified an …
Read more
Publication
Uncaria rhynchophylla (UR), a traditional Chinese medicine, has been proven effective in treating hypertensive patients in China. However, the mechanisms of action of UR in reducing hypertension and myocardial fibrosis are still unclear. The purpose of …
Read more
Publication
Rationale: Although a few injectable hydrogels have shown a reliable biosafety and a moderate promise in treating myocardial infarction (MI), the updated hydrogel systems with an on-demand biodegradation and multi-biofunctions to deliver therapeutic drug …
Read more
Publication
To explore the mechanism by which rosuvastatin prevents coronary microembolism (CME)-induced cardiac injury and cardiomyocyte apoptosis. Animal and cell models of CME were established and treated with different doses of rosuvastatin. Echocardiography and …
Read more
Publication
Sodium–glucose cotransporter 2 (SGLT2) inhibitors such as empagliflozin are known to reduce the risk of hospitalizations related to heart failure irrespective of diabetic state. Meanwhile, adverse cardiac remodeling remains the leading cause of heart …
Read more
Publication
Introduction: Cardiovascular disease and myocardial infarction are leading causes of morbidity and mortality in aged populations. Mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) are under evaluation as a therapeutic option for the …
Read more
Publication
Background. Chronic heart failure (CHF) is a serious heart disease resulting from cardiac dysfunction. Oxidative stress is an important factor in aging and disease. Butein, however, has antioxidant properties. To determine the effect of butein on …
Read more
Publication
Purpose: Obesity and diabetes are often accompanied by chronic inflammation and insulin resistance, which lead to complications such as diabetic cardiomyopathy. Ginsenoside Rb1 has been used to treat diabetes and obesity and reduce inflammation as well as …
Read more
Publication
After myocardial infarction (MI), adult mammals exhibit scar formation, adverse left ventricular (LV) remodeling, LV stiffening, and impaired contractility, ultimately resulting in heart failure. Neonatal mammals, however, are capable of natural heart …
Read more
Publication
Background. Qishen granules (QSG) are a frequently prescribed formula with cardioprotective properties prescribed to HF for many years. RNA-seq profiling revealed that regulation on cardiac mitochondrial energy metabolism is the main therapeutic effect. …
Read more

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 640
  • Page 641
  • Page 642
  • Page 643
  • Current page 644
  • Page 645
  • Page 646
  • Page 647
  • Page 648
  • …
  • Next page ››
  • Last page Last »
  • Warranty and Service
  • Product Retirement
  • Security
  • Accessibility
  • Modern Slavery Act
  • Privacy
  • Terms of Service

Contact

Call us at: 1.866.416.4636 | Europe: +31 20 808 2913 | Subscribe To Our Mailing List


VisualSonics, the VisualSonics logo, Vevo, Vevo MicroMarker and EKV are registered and unregistered trademarks of FUJIFILM Sonosite, Inc. in various jurisdictions. FUJIFILM is a registered trademark of FUJIFILM Corporation in various jurisdictions.

Copyright © 2026 FUJIFILM VisualSonics, Inc. All rights reserved. FUJIFILM VisualSonics, Inc is a subsidiary of FUJIFILM Sonosite, Inc.